本文已被:浏览 955次 下载 593次
投稿时间:2018-11-29 网络发布日期:2019-06-21
投稿时间:2018-11-29 网络发布日期:2019-06-21
中文摘要: 目的 探讨炔雌醇环丙孕酮片(达英-35)联合人绒毛膜促性腺激素(HCG)治疗多囊卵巢综合征(PCOS)患者的效果及其对血清骨钙素(OC)、血清性激素结合球蛋白(SHBG)水平的影响。方法 选择2015年2月至2017年4月接受治疗的136例PCOS患者作为研究对象,采用随机数字表法将其随机分为对照组(n=68)和联合组(n=68)。对照组患者给予达英-35口服治疗,联合组患者给予达英-35口服及HCG肌内注射治疗。治疗6个周期后,比较两组患者临床治疗效果及治疗前后体质指数(BMI)、腰臀比(WHR)、稳态模型的胰岛素抵抗指数(HOMA-IR)、性激素[卵泡刺激素(FSH)、黄体生成素(LH)、睾酮 (TT)]、OC、SHBG水平及治疗后两组患者排卵率和妊娠情况。结果 (1)联合组治疗总有效率95.59%,对照组75.00%,联合组显著高于对照组(χ2=11.450,P<0.01);(2)治疗后两组患者BMI和HOMA-IR较治疗前均显著降低(P<0.05),且联合组治疗后BMI、HOMA-IR且均低于对照组(P<0.01),治疗第6个周期后的WHR也显著低于对照组(P<0.01);(3)治疗后两组FSH、LH和T较治疗前均明显降低(P<0.05),且联合组治疗后FSH、LH和T均明显低于对照组治疗后(P<0.01);(4)治疗后两组患者血清OC和SHBG较治疗前均显著升高(P<0.05),且联合组治疗后血清OC和SHBG均显著高于对照组(P<0.05或P<0.01);(5)治疗后两组患者排卵率较治疗前均显著升高,且治疗3周期后和6周期后联合组排卵率(82.35%,89.71%)及妊娠率(29.41%,52.94%)均显著高于对照组(41.18%,51.47%;11.76%,25.00%)(χ2=24.410,23.942,6.476,11.161,P<0.05或P<0.01)。结论 PCOS患者存在血清OC和SHBG水平降低。达英-35口服联合HCG肌内注射治疗PCOS效果要明显优于单纯应用达英-35治疗,其可显著改善患者的高雄激素血症,调节内分泌紊乱和排卵障碍,促进患者血清OC和SHBG水平升高,提高患者的排卵率和妊娠率。
Abstract:ObjectiveTo investigate the effect of ethylene estradiol cycloprogesterone tablets (Diane 35) combined with human chorionic gonadotropin (HCG) on the treatment of polycystic ovarian syndrome (PCOS) and its influence on the levels of serum osteocalcin (OC) and sex hormone-binding globulin (SHBG). Methods A total of 136 PCOS patients treated from February 2015 to April 2017 were randomly divided into control group and combined group (n=68,each).Oral Diane 35 was given in control group,and Diane 35 combined with HCG intramuscular injection was given in combined group.The therapeutic effects,body mass index (BMI),whist hip ratio(WHR),homeostasis model assessment of insulin resistance(HOMA-IR),and the levels of sex hormones[follicle stimulating hormone(FSH),luteotropic hormone(LH),total testosterone (TT)],OC,SHBG before and after treatment,ovulation induction and pregnancy status (follicle maturation time,single follicle ovulation rate,ovulation rate and pregnancy rate) after treatment were compared between two groups. Results (1) The total effective rate was 95.56% in combined group and 75.56% in control group,and there was a significant difference between two groups (χ2=11.450,P<0.01).(2) After treatment,BMI and HOMA-IR were significantly lower than those before treatment in both groups (P<0.05) and were lower in combined group than those in control group (all P<0.01),After a six-cycle treatment,WHR was also significantly lower in combined group than that in control group (P<0.01).(3) After treatment,the levels of FSH,LH and TT were significantly lower than those before treatment in two groups (P<0.05) and were significantly lower in combined group than those in control group (all P<0.01).(4) After treatment,the serum OC and SHBG levels were significantly higher than those before treatment in both groups (P<0.05) and were significantly higher in combined group than those in control group (P<0.05 or P<0.01).(5) After treatment,the ovulation rate was significantly higher than that before treatment in two groups.After 3-,6-cycle treatment,the ovulation rates were 82.35%,89.71% respectively in combined group and 41.18%,51.47% respectively in control group,and the pregnancy rates were 29.41%,52.94%,respectively in combined group and 11.76%,25.00%,respectively in control group (χ2= 24.410,23.942,6.476,11.161,P<0.05 or P<0.01). Conclusion Oral Diane 35 combined with intramuscular injection of HCG has more advantages in reducing hyperandrogenism,regulating endocrine disorders and ovulation disorders,promoting the increase of serum OC and SHBG levels and increasing the ovulation rate and pregnancy rate of patients.
keywords: Polycystic ovary syndrome Ethylene estradiol cycloprogesterone tablets Human chorionic gonadotropin Osteocalcin Sex hormone binding globulin Follicle stimulating hormone Luteotropic hormone Testosterone
文章编号: 中图分类号:R 711.75 文献标志码:A
基金项目:
附件
Author Name | Affiliation |
GUO Rui,FANG Zhen-ya | Shandong Maternal and Child Health Hospital,Jinan,Shandong 250014,China |
引用文本:
郭锐,房振亚.炔雌醇环丙孕酮片联合绒毛膜促性腺激素治疗多囊卵巢综合征[J].中国临床研究,2019,32(6):784-788.
郭锐,房振亚.炔雌醇环丙孕酮片联合绒毛膜促性腺激素治疗多囊卵巢综合征[J].中国临床研究,2019,32(6):784-788.